The importance of CD28 in vivo has been demonstrated through the use of anti-CD28 therapies to induce immunosuppression following transplantation, in patients with autoimmune diseases (reviewed in [79]) and during cancer immunotherapies via CD28 activation [80]. The gene discussed is CD28; the disease is cancer.